Shigella vaccine - Emergent Biosolutions
Alternative Names: Shigella-ETEC - Emergent BiosolutionsLatest Information Update: 25 Sep 2021
At a glance
- Originator Emergent BioSolutions
- Class Attenuated vaccines; Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Diarrhoea
Most Recent Events
- 16 Jun 2021 Preclinical trials in Diarrhoea (Prevention) in USA (unspecified route) (Emergent BioSolutions pipeline, June 2021)
- 16 Jun 2021 Emergent BioSolutions plans a phase I trial in Diarrhoea (Prevention) in 2021 (Emergent BioSolutions pipeline, June 2021)